Methods of preparing Tecovirimat

Inventors

Dai, Dongcheng

Assignees

Siga Technologies Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-10029985-B2

Patent

Publication Date

2018-07-24

Expiration Date


Abstract

Disclosed are methods for the preparation of Tecovirimat for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by the orthopoxvirus.

Core Innovation

The partial content describes a method for producing Tecovirimat (ST-246) through a synthetic route that uses a series of intermediate compounds and a final reaction involving cycloheptatriene. The claimed method is presented as Route III among multiple disclosed preparation pathways. At a high level, the innovation is the specified sequence of intermediate formation and conversion to the target benzamide.

The provided partial content does not include the background section, so it does not explicitly describe the problem being solved. It identifies the claimed route as one among multiple disclosed synthetic routes to Tecovirimat and reports example product yield and purity, but it does not state a specific limitation of earlier preparation methods that the claimed route addresses.

Claims Coverage

The relevant claims identify one independent claim, which covers a method for producing Tecovirimat through a specified sequence of intermediate formation and conversion to the final benzamide. Dependent claims refine reagent identity, reaction conditions, and purification.

Synthetic route to Tecovirimat

The independent claim covers producing Tecovirimat through formation and conversion of intermediate compounds, followed by a final reaction involving cycloheptatriene and collection of the product. [procedural detail omitted for safety]

The claims center on one synthetic method for producing Tecovirimat, with dependent claims specifying refinements to reagents, reaction conditions, and product purification.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Production of Tecovirimat (ST-246), the benzamide identified in the independent claim.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.